Treatment Info For Arthritis (Continued)

Treatment of Arthritis with Rife machine

About Royal Raymond Rife

Royal Raymond Rife was an inventor and genius who won scientist of the year awards twice. He started looking for a cancer cure in 1920. By 1934 he cured 16 out of 16 (100% success) cancer patients in his clinic, every one within 3 months. What he invented first was a microscope that used prisms and various light types other than white and was so powerful he could watch viruses alive and experiment on them without destroying them in the process.

In Australia, a serious placebo (sometimes called double blind) study was made to demonstrate the effectiveness of using audio frequency therapy in the treatment of arthritis using a prototype of the PET Rife-Crane unit. Behind this study is, amongst others, Geoff Baker (B.App. Sci) who spent years of his life and millions of dollars studying and perfecting his PET device. In order to achieve medical approval for the sale of the PET unit in Australia, this Placebo study was made under scientifically controlled circumstances.

The Study results suggest that

Audio Frequency Therapy is highly effective in the treatment of Osteo and Rheumatoid Arthritis. After 36 three-hour treatment sessions of Audio Frequency Therapy, the net mean overall improvement in the arthritic condition of treated volunteers (irrespective of type of arthritis suffered) was approximately 25 percent

·	Continued reduction of pain levels under the extended treatment sessions administered to Group C (72 three hour treatment sessions, fig 4) suggest that the benefits of Audio Frequency Therapy are cumulative and in proportion to the number of treatment sessions a patient undergoes.

Extrapolation of the mean improvement rate of all treated volunteers in considering the "worst case" situation suggests that it may be possible to completely eliminate many Arthritis signs and symptoms in any sufferer of Osteo or Rheumatoid Arthritis in less than twelve months with an AFTU treatment program of three, three hour sessions per week.

·	Frequency Therapy may relieve all arthritis symptoms permanently. This may be possible if the underlying causative factors are also dealt with and the patient is given time to heal. A cleansing dietary regimen would be considered essential in all cases.

·	Audio Frequency Therapy may relieve pain, swelling and inflammation in all arthritis affected areas, but will leave pain in joints which have suffered major degeneration

·	I.e. moderate to complete breakdown of articular cartilage leaving exposed bone .

·	No significant adverse side effects may be expected within the short term i.e. less than 12 months (based on clinical experience) if the above treatment protocol is adhered to and the Audio Frequency Therapy Unit operation manual closely followed.

The study was initiated by a private company, BWBGELTECH PTY LTD seeking assistance from an arthritis support organisation, interested doctors, and a commercial laboratory.

Placebo study conditions were strictly adhered to, with no volunteer being aware of whether he or she was receiving treatment. Three treatments per week of three hours duration were administered using thirty-four Audio Frequency Therapy Units . These pocket sized computerised devices allowed carefully selected menus of frequency programs to be applied to each chosen volunteer.

All participants were regularly monitored by self-evaluation of pain on visual analogue scales, which complied with a standard hospital protocol for monitoring pain in arthritis patients. Also pre and post study HLB testing was provided by Australian Biologics Testing Services (Sydney) for seven randomly selected volunteers from the treated and placebo groups. Similarly, independent post-study appraisal of each volunteer's condition by their referring General Practitioner was requested.

On completion of the study, the mean value of percentage reduction in overall pain (of the treated group was 34 percent compared with 13 percent reduction in the untreated group (The mean 13 percent reduction of pain in the untreated volunteers was generally attributable to the emotional benefits received by being involved in the study. This improvement was not evidenced in the blood test results.
Long term side effects are unknown but may be similar in nature to TENS therapy. Continuous treatment with Audio Frequency Therapy Units over twelve months is not recommended.

After this study was complete, Geoff Baker formed Electromed to build and market a commercial version of the Audio Frequency Therapy unit described here. The commercial version is called PET and it is described on the electromed web site

There is a wealth of testimonies on the rife forum website which testify to the effectiveness of this treatment http://www.rife.de/